HQ - Strasbourg
Summary
NovAliX is a drug discovery CRO supporting therapeutic programs from target identification to preclinical candidates using advanced chemistry, pharmacology, and biophysical techniques.
Deals Overview
Senior Management
Denis Zeyer
CEO
Christophe Dubost
CFO
Stephan Jenn
Co-Founder
All rights reserved. Copyright © 2025 Datasite